Erdafitinib

About

Therapy type: Targeted therapy

Therapy strategy: FGFR inhibition

Mappings

NCI Thesaurus: Erdafitinib (ncit:C103273)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy.

Type Biomarker(s) Cancer type Therapy(ies)
Sensitivity (+) FGFR3 p.R248C Bladder Urothelial Carcinoma Erdafitinib
Sensitivity (+) FGFR3 p.S249C Bladder Urothelial Carcinoma Erdafitinib
Sensitivity (+) FGFR3 p.G370C Bladder Urothelial Carcinoma Erdafitinib
Sensitivity (+) FGFR3 p.Y373C Bladder Urothelial Carcinoma Erdafitinib
Sensitivity (+) FGFR3::TACC3 Bladder Urothelial Carcinoma Erdafitinib
Sensitivity (+) FGFR3 p.R248C Bladder Urothelial Carcinoma Erdafitinib
Sensitivity (+) FGFR3 p.S249C Bladder Urothelial Carcinoma Erdafitinib
Sensitivity (+) FGFR3 p.G370C Bladder Urothelial Carcinoma Erdafitinib
Sensitivity (+) FGFR3 p.Y373C Bladder Urothelial Carcinoma Erdafitinib
Sensitivity (+) FGFR3::TACC3 Bladder Urothelial Carcinoma Erdafitinib
Sensitivity (+) FGFR2::BICC1 Bladder Urothelial Carcinoma Erdafitinib
Sensitivity (+) FGFR2::CASP7 Bladder Urothelial Carcinoma Erdafitinib
Sensitivity (+) FGFR3::BAIAP2L1 Bladder Urothelial Carcinoma Erdafitinib
Sensitivity (+) FGFR3 p.R248C Bladder Urothelial Carcinoma Erdafitinib
Sensitivity (+) FGFR3 p.S249C Bladder Urothelial Carcinoma Erdafitinib
Sensitivity (+) FGFR3 p.G370C Bladder Urothelial Carcinoma Erdafitinib
Sensitivity (+) FGFR3 p.Y373C Bladder Urothelial Carcinoma Erdafitinib
Sensitivity (+) FGFR3::TACC3 Bladder Urothelial Carcinoma Erdafitinib
Sensitivity (+) FGFR2::BICC1 Bladder Urothelial Carcinoma Erdafitinib
Sensitivity (+) FGFR2::CASP7 Bladder Urothelial Carcinoma Erdafitinib
Sensitivity (+) FGFR3::BAIAP2L1 Bladder Urothelial Carcinoma Erdafitinib